Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the Hospital Readmission Reduction Program

American Journal of Infection Control

Volumn 43, Issue 4, 2015, Pages 314-317

  Chopra, Teena ^a   Neelakanta, Anupama ^a   Dombecki, Carolyn ^a   Awali, Reda A ^a   Sharma, Sarit ^a   Kaye, Keith S ^a   Patel, Paru ^a  

^a HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

30 day readmissions; Centers for Medicare and Medicaid Services; Clostridium difficile

Indexed keywords

ADULT; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; HEALTH CARE SYSTEM; HEALTH PROGRAM; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; ICD-9; LENGTH OF STAY; MAJOR CLINICAL STUDY; MIDDLE AGED; TERTIARY HEALTH CARE; YOUNG ADULT; ADOLESCENT; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; INTERNATIONAL CLASSIFICATION OF DISEASES; PEPTOCLOSTRIDIUM DIFFICILE; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LENGTH OF STAY; MIDDLE AGED; PATIENT READMISSION; UNITED STATES; YOUNG ADULT;

EID: 84933039123     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2014.11.004     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention (CDC). Vital signs: Central lineassociated blood stream infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011;60: 243-8.
2. Steiner C, Barrett M, Terrel L. HCUP projections: Clostridium Difficile hospitalizations 2011 to 2012. Available from: Http://www.hcup-us.ahrq.gov/reports/projections/CDI-Regional-projections-Final.pdf; 2012. Accessed April 25, 2014.
3. McFarland LV, Surawicz CM, Rubin M, Fekety R, Elmer GW, Greenberg RN. Recurrent Clostridium difficile disease: Epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 1999;20: 43-50.
4. Kelly CP, LaMont JT. Clostridium difficileemore difficult than ever. N Engl J Med 2008;359: 1932-40.
5. Murphy CR, Avery TR, Dubberke ER, Huang SS. Frequent hospital readmissions for Clostridium difficile infection and the impact on estimates of hospitalassociated C. difficile burden. Infect Control Hosp Epidemiol 2012;33: 20-8.
6. Centers for Medicare and Medicaid Services (CMS), HHS. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and Fiscal Year 2014 rates; quality reporting requirements for specific providers; hospital conditions of participation; payment policies related to patient status. Final rules. Fed Regist 2013;78: 50495-1040.
7. Lipp MJ, Nero DC, Callahan MA. Impact of hospital-acquired Clostridium difficile. J Gastroenterol Hepatol 2012;27: 1733-7.
8. Noren T, Akerlund T, Back E, Sjöberg L, Persson I, Alriksson I, et al. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol 2004;42: 3635-43.
9. Elixhauser A, Steiner C, Gould C. Readmissions following hospitalizations with Clostridium difficile infections, 2009: Statistical brief #145. Rockville [MD]: Agency for Health Care Policy and Research; 2006.
10. Joynt KE, Orav EJ, Jha AK. Thirty-day readmission rates for Medicare beneficiaries by race and site of care. JAMA 2011;305: 675-81.
11. Centers for Medicare and Medicaid Services. Fact sheets: CMS final rule to improve quality of care during hospital inpatient stays. Available from: Http://www.cms.gov/newsroom/mediareleasedatabase/fact-sheets/2013-fact-sheetsitems/2013-08-02-3.html. Accessed July 13, 2014.
12. AAMC. Hospital Acquired Condition (HAC) Reduction Program. Available from: Https://www.aamc.org/download/353228/data/aamctothepointhac.pdf. Accessed July 13, 2014.
13. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, US Department of Health and Human Services. Available at: Http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf; 2013. Accessed July 13, 2014.
14. Fridkin S, Baggs J, Fagan R, Magill S, Pollack LA, Malpiedi P, et al. Vital signs: Improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep 2014;63: 194-200.
15. Sherman ER, Heydon KH, St John KH, Teszner E, Rettig SL, Alexander SK, et al. Administrative data fail to accurately identify cases of healthcare-associated infection. Infect Control Hosp Epidemiol 2006;27: 332-7.